Bathi sadurunge mbayar bunga, pajak, lan amortisasi: intelliatx.com (NTLA)
Intellia Therapeutics (NTLA) develops innovative treatments for hereditary pathologies. On GURU.Markets, the EBITDA trend visualizes the scaling potential of gene therapy, where the current status is 0.00. Business stability relies on the ownership of CRISPR patents and a strong scientific foundation. Meanwhile, the company's success is based on R&D pipeline results and strict control over the expenditure of existing cash reserves.
Intellia Therapeutics, Inc. - rincian analitis lan metrik utama (NTLA)
- rega saham lan target rega konsensus:
- indikator kapitalisasi bursa perusahaan:
- rincian valuasi buku bisnis:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Intellia Therapeutics|NTLA - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Intellia Therapeutics Inc|NTLA - Gunggung utang perusahaan|Rasio utang marang aset resik Intellia Therapeutics|NTLA - Utang jangka dawa perusahaan|Utang jangka cendhak Intellia Therapeutics|Rasio jangkoan perantara intelliatx.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
NTLA - Bathi resik|Proyeksi bathi mangsa ngarep Intellia Therapeutics|NTLA - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake intelliatx.com|NTLA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Intellia Therapeutics|NTLA - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Intellia Therapeutics|NTLA - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan intelliatx.com|NTLA - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Intellia Therapeutics
Ringkesan analitik perusahaan:Intellia Corp
Intellia Therapeutics (NTLA) is developing high-risk CRISPR technologies, where the lack of profitability depends on the outcome of clinical trials. This indicator measures the actual cash flow from core operations before depreciation and interest. Negative values signal high development costs and a reliance on external financing. Investors should assess the burn rate via the annual EBITDA figure. This chart reflects the efficiency of cost management under regulatory pressure.
Karo sapa Intellia Therapeutics saingan
Tempus - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|QGEN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|IONS: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|RGEN: Bathi operasional EBITDA|RNA - Pendapatan operasional sadurunge ngurangi amortisasi|CRSP (CRISPR Therapeutics Corp) - Bathi operasional EBITDA|Bathi operasional EBITDA GeneDx Corp|Bathi operasional sadurunge ngurangi amortisasi RARE (Ultragenyx Pharmaceutical)|BEAM (beamtx.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Sarepta - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TWST (Twist Bioscience Inc)|10x Genomics Corp - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi STOK (Stoke Corp)|BLFS: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi wavelifesciences.com (WVE)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Maze Therapeutics|SION: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA PRME|Bathi operasional EBITDA Taysha Corp (TSHA)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi uniQure N.V. QURE|MGTX (meiragtx.com) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|REGENXBIO - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Solid Biosciences Inc|OCGN (Ocugen Corp) - Bathi operasional sadurunge ngurangi amortisasi|PacBio Corp (PACB) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi BNTC|DSGN (designtx.com) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi operasional EBITDA RCKT|Pendapatan operasional sadurunge ngurangi amortisasi 4DMT|Bathi operasional EBITDA LXEO (Lexeo Therapeutics, Inc.)|KRRO - Bathi operasional sadurunge ngurangi amortisasi|EDIT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi silence-therapeutics.com SLN|proqr.com (PRQR) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi CDXS|Bathi operasional sadurunge ngurangi amortisasi SGMO|NAUT (Nautilus Biotechnology Inc) - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Metagenomi, Inc. (MGX)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi DTIL (precisionbiosciences.com)|Bathi operasional EBITDA GBIO (Generation Bio)|Bathi operasional EBITDA Boundless Bio Inc. BOLD|Exicure Corp - Bathi operasional EBITDA|IMNN (Imunon, Inc.) - Bathi operasional sadurunge amortisasi|phiopharma.com (PHIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge amortisasi MBIO|RNAZ (TransCode Therapeutics Inc.) - Bathi operasional EBITDA|Bathi operasional EBITDA Bionano|Bathi operasional EBITDA APDN|Pendapatan operasional sadurunge ngurangi amortisasi bluebird bio, Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ImmunoPrecise Antibodies Ltd. IPA|OMGA: Bathi operasional sadurunge amortisasi|OMIC: Bathi operasional sadurunge ngurangi amortisasi|Regulus Therapeutics, Inc. - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|SYRS: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Telesis Bio, Inc (TBIO)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TRACON Pharmaceuticals|Bathi sadurunge mbayar bunga, pajak, lan amortisasi UBX
